T39 — Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
Is T39 billable?
No — T39 is a non-billable header code. T39 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 60 billable codes beneath T39.
Billable codes under this header
- T39.91XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter
- T39.91XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter
- T39.91XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), sequela
- T39.92XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter
- T39.92XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter
- T39.92XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela
- T39.93XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter
- T39.93XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter
- T39.93XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, sequela
- T39.94XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter
- T39.94XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter
- T39.94XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, sequela
- T39.95XAAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T39.95XDAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
- T39.95XSAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
- T39.96XAUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T39.96XDUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
- T39.96XSUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
- T39.011APoisoning by aspirin, accidental (unintentional), initial encounter
- T39.011DPoisoning by aspirin, accidental (unintentional), subsequent encounter
- T39.011SPoisoning by aspirin, accidental (unintentional), sequela
- T39.012APoisoning by aspirin, intentional self-harm, initial encounter
- T39.012DPoisoning by aspirin, intentional self-harm, subsequent encounter
- T39.012SPoisoning by aspirin, intentional self-harm, sequela
- T39.013APoisoning by aspirin, assault, initial encounter
- T39.013DPoisoning by aspirin, assault, subsequent encounter
- T39.013SPoisoning by aspirin, assault, sequela
- T39.014APoisoning by aspirin, undetermined, initial encounter
- T39.014DPoisoning by aspirin, undetermined, subsequent encounter
- T39.014SPoisoning by aspirin, undetermined, sequela
- T39.015AAdverse effect of aspirin, initial encounter
- T39.015DAdverse effect of aspirin, subsequent encounter
- T39.015SAdverse effect of aspirin, sequela
- T39.016AUnderdosing of aspirin, initial encounter
- T39.016DUnderdosing of aspirin, subsequent encounter
- T39.016SUnderdosing of aspirin, sequela
- T39.091APoisoning by salicylates, accidental (unintentional), initial encounter
- T39.091DPoisoning by salicylates, accidental (unintentional), subsequent encounter
- T39.091SPoisoning by salicylates, accidental (unintentional), sequela
- T39.092APoisoning by salicylates, intentional self-harm, initial encounter
- T39.092DPoisoning by salicylates, intentional self-harm, subsequent encounter
- T39.092SPoisoning by salicylates, intentional self-harm, sequela
- T39.093APoisoning by salicylates, assault, initial encounter
- T39.093DPoisoning by salicylates, assault, subsequent encounter
- T39.093SPoisoning by salicylates, assault, sequela
- T39.094APoisoning by salicylates, undetermined, initial encounter
- T39.094DPoisoning by salicylates, undetermined, subsequent encounter
- T39.094SPoisoning by salicylates, undetermined, sequela
- T39.095AAdverse effect of salicylates, initial encounter
- T39.095DAdverse effect of salicylates, subsequent encounter
- T39.095SAdverse effect of salicylates, sequela
- T39.096AUnderdosing of salicylates, initial encounter
- T39.096DUnderdosing of salicylates, subsequent encounter
- T39.096SUnderdosing of salicylates, sequela
- T39.1X1APoisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
- T39.1X1DPoisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter
- T39.1X1SPoisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela
- T39.1X2APoisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
- T39.1X2DPoisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter
- T39.1X2SPoisoning by 4-Aminophenol derivatives, intentional self-harm, sequela
T39 at a glance
| Code | T39 |
|---|---|
| Description | Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T39 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T39. T39 describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T39 to fully describe the condition. T39 is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T39 to fully describe the condition. T39 is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T39, but a patient may have both at the same time. When documentation supports it, T39 and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T39, but a patient may have both at the same time. When documentation supports it, T39 and the excluded code may both be reported.
What codes fall under T39? (7)
- T39.0Poisoning by, adverse effect of and underdosing of salicylatesnot billable
- T39.1Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivativesnot billable
- T39.2Poisoning by, adverse effect of and underdosing of pyrazolone derivativesnot billable
- T39.3Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID]not billable
- T39.4Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classifiednot billable
- T39.8Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classifiednot billable
- T39.9Poisoning by, adverse effect of and underdosing of unspecified nonopioid analgesic, antipyretic and antirheumaticnot billable
How long has T39 existed?
T39 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.